Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,495 | -7,761 | -34,978 | -23,523 | -15,285 |
| Depreciation Amortization | 935 | 469 | 2,000 | 1,468 | 1,003 |
| Accounts receivable | -5,305 | -904 | 208 | -1,701 | 233 |
| Other Working Capital | -9,990 | -100 | 1,667 | -1,228 | -3,682 |
| Other Operating Activity | 5,272 | 1,051 | -64 | 2,080 | 18 |
| Operating Cash Flow | $-19,583 | $-7,245 | $-31,167 | $-22,904 | $-17,713 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,367 | -1,085 | -1,146 | -989 | -307 |
| Purchase Sale Intangibles | -13 | N/A | -67 | -50 | -50 |
| Other Investing Activity | -13 | 0 | -117 | -97 | -97 |
| Investing Cash Flow | $-1,380 | $-1,085 | $-1,263 | $-1,086 | $-403 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 573 | 570 | 1,068 | 1,023 | 1,005 |
| Debt Issued | N/A | N/A | 21,363 | 16,364 | 16,076 |
| Debt Repayment | -926 | -494 | -13,367 | -12,374 | -11,681 |
| Common Stock Issued | N/A | N/A | 24,217 | 23,188 | 22,780 |
| Other Financing Activity | -1,049 | -806 | 10,456 | -4,332 | -3,021 |
| Financing Cash Flow | $-1,402 | $-730 | $43,737 | $23,870 | $25,159 |
| Exchange Rate Effect | -759 | -292 | 46 | -180 | 22 |
| Beginning Cash Position | 48,068 | 47,799 | 36,463 | 34,914 | 34,300 |
| End Cash Position | 24,943 | 38,448 | 47,816 | 34,615 | 41,366 |
| Net Cash Flow | $-23,124 | $-9,351 | $11,353 | $-299 | $7,066 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,583 | -7,245 | -31,167 | -22,904 | -17,713 |
| Capital Expenditure | -1,400 | -1,085 | -1,158 | -1,001 | -318 |
| Free Cash Flow | -20,983 | -8,329 | -32,325 | -23,905 | -18,031 |